These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 11527096

  • 1. Activation of the hypothalamic-pituitary-adrenal axis in obesity: cause or consequence?
    Walker BR.
    Growth Horm IGF Res; 2001 Jun; 11 Suppl A():S91-5. PubMed ID: 11527096
    [Abstract] [Full Text] [Related]

  • 2. Tissue-specific dysregulation of cortisol metabolism in human obesity.
    Rask E, Olsson T, Söderberg S, Andrew R, Livingstone DE, Johnson O, Walker BR.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1418-21. PubMed ID: 11238541
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver.
    Westerbacka J, Yki-Järvinen H, Vehkavaara S, Häkkinen AM, Andrew R, Wake DJ, Seckl JR, Walker BR.
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4924-31. PubMed ID: 14557475
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
    Stewart PM, Toogood AA, Tomlinson JW.
    Horm Res; 2001 Oct; 56 Suppl 1():1-6. PubMed ID: 11786677
    [Abstract] [Full Text] [Related]

  • 7. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
    Livingstone DE, Walker BR.
    J Pharmacol Exp Ther; 2003 Apr; 305(1):167-72. PubMed ID: 12649365
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Obesity and gender influence cortisol secretion and metabolism in man.
    Andrew R, Phillips DI, Walker BR.
    J Clin Endocrinol Metab; 1998 May; 83(5):1806-9. PubMed ID: 9589697
    [Abstract] [Full Text] [Related]

  • 10. Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.
    Stewart PM.
    Eur J Endocrinol; 2003 Sep; 149(3):163-8. PubMed ID: 12943516
    [Abstract] [Full Text] [Related]

  • 11. Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease.
    Walker BR, Andrew R.
    Ann N Y Acad Sci; 2006 Nov; 1083():165-84. PubMed ID: 17148739
    [Abstract] [Full Text] [Related]

  • 12. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
    Stimson RH, Walker BR.
    Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154
    [Abstract] [Full Text] [Related]

  • 13. 11beta-Hydroxysteroid Dehydrogenase Type 1 Regulation by Intracellular Glucose 6-Phosphate Provides Evidence for a Novel Link between Glucose Metabolism and Hypothalamo-Pituitary-Adrenal Axis Function.
    Walker EA, Ahmed A, Lavery GG, Tomlinson JW, Kim SY, Cooper MS, Ride JP, Hughes BA, Shackleton CHL, McKiernan P, Elias E, Chou JY, Stewart PM.
    J Biol Chem; 2007 Sep 14; 282(37):27030-27036. PubMed ID: 17588937
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
    Baudrand R, Domínguez JM, Carvajal CA, Riquelme A, Campino C, Macchiavello S, Bozinovic M, Morales M, Pizarro M, Solis N, Escalona A, Boza C, Arrese M, Fardella CE.
    Metabolism; 2011 Dec 14; 60(12):1775-80. PubMed ID: 21704348
    [Abstract] [Full Text] [Related]

  • 15. [Correlations between the hypothalamo-pituitary-adrenal axis and the metabolic syndrome].
    Góth M, Hubina E, Korbonits M.
    Orv Hetil; 2005 Jan 09; 146(2):51-5. PubMed ID: 15724952
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Biomarkers of hypothalamic-pituitary-adrenal axis activity in mice lacking 11β-HSD1 and H6PDH.
    Abrahams L, Semjonous NM, Guest P, Zielinska A, Hughes B, Lavery GG, Stewart PM.
    J Endocrinol; 2012 Sep 09; 214(3):367-72. PubMed ID: 22718432
    [Abstract] [Full Text] [Related]

  • 19. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
    Tsilchorozidou T, Honour JW, Conway GS.
    J Clin Endocrinol Metab; 2003 Dec 09; 88(12):5907-13. PubMed ID: 14671189
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.